ACTAVIS LLC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?
ACTAVIS LLC has seven approved drugs.
There are two tentative approvals on ACTAVIS LLC drugs.
Summary for ACTAVIS LLC
US Patents: | 0 |
Tradenames: | 5 |
Ingredients: | 5 |
NDAs: | 7 |
Patent Litigation for ACTAVIS LLC: | See patent lawsuits for ACTAVIS LLC |
PTAB Cases with ACTAVIS LLC as petitioner: | See PTAB cases with ACTAVIS LLC as petitioner |
Drugs and US Patents for ACTAVIS LLC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Llc | AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 208216-001 | Apr 29, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Llc | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | POWDER;INTRAVENOUS | 206516-001 | Feb 13, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Llc | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 206018-001 | Dec 19, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.